Related Experiment Video
Updated: Dec 27, 2025

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Toxicity of Atenolol and Propranolol on Rat Heart Mitochondria
Enayatollah Seydi1,2, Yasaman Tabbati3, Jalal Pourahmad3
1Department of Occupational Health and Safety Engineering, School of Health, Alborz University of Medical Sciences, Karaj, Iran.
Abstract:
Propranolol and atenolol are known as β receptor blocker drugs. These drugs are used to treat some heart diseases. There are controversies in the relationship between the use of beta-blocker drugs and the level of reactive oxygen species (ROS). Mitochondria as one of the most important sources of ROS are considered as one of the targets of drug-induced cardiotoxicity. The aim of this study was to evaluate the effects of propranolol and atenolol on mitochondria isolated from the heart. To achieve this aim, several markers of mitochondrial and cellular toxicity were evaluated. The key results of this study are the increased ROS level, collapse in mitochondrial membrane potential (MMP), mitochondrial swelling and cytochrome c release as well as disruption of respiratory chain complex II in mitochondria in isolated heart mitochondria after exposure to propranolol and atenolol. The results indicate an increase in caspase-3 activity and a decrease in the ATP level in cardiomyocytes after exposure to propranolol and atenolol. The underlying mechanisms of propranolol and atenolol induced cardiotoxicity may be associated with alterations in mitochondrial function, oxidative stress, and changes in the mitochondrial membrane.
Insights
Beta-blockers like propranolol and atenolol may harm heart mitochondria by increasing reactive oxygen species (ROS) and impairing function. This study reveals potential cardiotoxicity mechanisms linked to oxidative stress and mitochondrial damage.
Area of Science:
- Cardiovascular Pharmacology
- Mitochondrial Toxicology
- Biochemistry
Background:
- Beta-blockers, including propranolol and atenolol, are widely used for cardiac conditions.
- Controversies exist regarding the impact of beta-blockers on reactive oxygen species (ROS) production.
- Mitochondria are key sources of ROS and potential targets for drug-induced cardiotoxicity.
Purpose of the Study:
- To investigate the effects of propranolol and atenolol on isolated heart mitochondria.
- To evaluate specific markers of mitochondrial and cellular toxicity induced by these beta-blockers.
Main Methods:
- Isolation of mitochondria from heart tissue.
- Assessment of mitochondrial membrane potential (MMP).
- Measurement of ROS levels, mitochondrial swelling, and cytochrome c release.
- Evaluation of respiratory chain complex II activity.
- Analysis of caspase-3 activity and ATP levels in cardiomyocytes.
Main Results:
- Propranolol and atenolol exposure led to increased ROS levels in isolated heart mitochondria.
- A significant collapse in MMP, mitochondrial swelling, and cytochrome c release were observed.
- Disruption of respiratory chain complex II activity was evident.
- Cardiomyocytes showed increased caspase-3 activity and decreased ATP levels.
Conclusions:
- Propranolol and atenolol can induce cardiotoxicity through mechanisms involving mitochondrial dysfunction.
- Oxidative stress and alterations in mitochondrial membrane integrity are implicated in this toxicity.
- These findings highlight potential risks associated with beta-blocker use and warrant further investigation.
Related Concept Videos
Antihypertensive Drugs: Types of β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

